3.5.1. renal medullary carcinoma (smarcb1-deficient renal medullary carcinoma). renal medullary carcinoma (rmc) (referred smarcb1-deficient renal medullary carcinoma 2022 classification) rare tumour, comprising < 0.5% rccs , predominantly diagnosed young adults african ancestry (median age 28 years) sickle haemoglobinopathies (including sickle cell trait). male predominance 2:1 mainly centrally located ill-defined borders. renal medullary carcinoma one aggressive rccs patients (~67%) present metastatic disease . even patients present seemingly localised disease may develop unequivocal metastases shortly (within weeks) diagnosis (for treatment see chapter 7). apart rmc described above, patients present identical tumours without haemoglobinopathy. tumours described “unclassified rcc medullary phenotype” .